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systematic review and meta-analysis
Takawira C Marufu1, Anand Ahankari1,2, Tim Coleman3 and Sarah Lewis1*Abstract
Background: Smoking in pregnancy is known to be associated with a range of adverse pregnancy outcomes, yet
there is a high prevalence of smoking among pregnant women in many countries, and it remains a major public
health concern. We have conducted a systematic review and meta-analysis to provide contemporary estimates of
the association between maternal smoking in pregnancy and the risk of stillbirth.
Methods: We searched four databases namely MEDLINE, EMBASE, Psych Info and Web of Science for all relevant
original studies published until 31st December 2012. We included observational studies that measured the
association between maternal smoking during pregnancy and the risk of stillbirth.
Results: 1766 studies were screened for title analysis, of which 34 papers (21 cohorts, 8 case controls and 5 cross
sectional studies) met the inclusion criteria. In meta-analysis smoking during pregnancy was significantly associated
with a 47% increase in the odds of stillbirth (OR 1.47, 95% CI 1.37, 1.57, p < 0.0001). In subgroup analysis, smoking
1-9 cig/day and ≥10 cig/day was associated with an 9% and 52% increase in the odds of stillbirth respectively.
Subsequently, studies defining stillbirth at ≥ 20 weeks demonstrated a 43% increase in odds for smoking mothers
compared to mothers who do not smoke, (OR 1.43, 95% CI 1.32, 1.54, p < 0.0001), whereas studies with stillbirth
defined at ≥ 24 weeks and ≥ 28 weeks showed 58% and 33% increase in the odds of stillbirth respectively.
Conclusion: Our review confirms a dose-response effect of maternal smoking in pregnancy on risk of stillbirth. To
minimise the risk of stillbirth, reducing current smoking prevalence in pregnancy should continue to be a key public
health high priority.Background
Smoking in pregnancy is a major public health problem
in the developed countries [1]. The World Health
Organisation (WHO) predicts that this will reach ‘epidemic’
proportions in developing countries in the near future
[1]. Within the current challenging economic climate in
many countries, smoking in pregnancy imposes a sig-
nificant burden on population health and resources, and
is associated with a range of poor outcomes for both
mother and child, such as ectopic pregnancy, miscar-
riage, placental abruption, preterm birth and low birth
weight [2,3]. The harmful effects of tobacco smoke ex-
posure in pregnancy can be avoided [4] and it is one of* Correspondence: Sarah.lewis@nottingham.ac.uk
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unless otherwise stated.the most prevalent modifiable risk factors for adverse
pregnancy outcomes [5,6].
In many developed countries, the rates of smoking in
pregnancy have been declining over recent decades [7]
with current prevalence estimates between 10% – 19% [8],
and data from the UK suggesting that one out of eight
women smoke throughout the pregnancy [9]. Moreover,
this decline has not been consistent across all social classes;
lower rates of decline have been noted across less advan-
taged socioeconomic groups [10]. Smoking in pregnancy
in developed countries tends to be higher among women
who have low income and poor education [11].
Stillbirth rates widely vary across low, middle and
high-income countries [12-14]. The lowest rates have
been observed in Finland with 2.0 per 1000 live births
and in the developing world rates are much higher at
more than 40 per 1000 live births in countries like
Nigeria and Pakistan [6]. Two previous systematic re-
views and meta-analyses have estimated the size of effect. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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report by the United States Surgeon General [15]
showed a relative risk of stillbirth of 1.2-1.8 within
smokers versus non-smokers. The analysis was based on
three studies [16-18] conducted in two countries, the
United States and Sweden. Recent stillbirth statistics by
Flenady et al [8] was based on a systematic review from
high-income countries; and four studies were included
in the meta-analysis of the association between any
smoking in pregnancy and the risk of stillbirth yielding
an odds ratio of 1.36 (95% CI 1.27, 1.46). Results from
these published reviews were limited to literature from
developed countries; yet stillbirth rates are much higher
in developing countries, and it is therefore imperative to
conduct a comprehensive review, which reflects the im-
pact of smoking in pregnancy on stillbirth. We have
conducted a systematic review and meta-analysis to pro-
vide contemporary estimates of the association between
maternal smoking in pregnancy and the risk of stillbirth.
Methods
A detailed electronic search was performed through four
databases namely MEDLINE, EMBASE, Psych Info and
Web of Science. All relevant published studies with suf-
ficient data on maternal cigarette or tobacco smoking
during pregnancy with the outcome of stillbirth were in-
cluded. Due to the nature of the research objective, there
were no randomised control trials (RCTs) identified, and
observational studies (such as cohort design, case con-
trol studies and cross sectional surveys) were considered
using the standard guidelines of Meta-analysis of Obser-
vational Studies in Epidemiology (MOOSE) [19]. All
relevant studies published in the English language, up to
31st December 2012 were included in the review. Case
reports, non-English publications and those, which only
involved passive or environmental smoke information,
were excluded. We carefully considered studies where
the study populations were similar to avoid duplication
of cases; where studies were based on exactly the same
population during the same time period, but there were
differences in sample sizes, we selected the results from
the publication with the larger sample size for inclusion
in the meta-analysis, though those excluded from quan-
titative analysis were included in a narrative synthesis.
Search strategy
We developed search terms based on medical subject
headings (MeSH), free text words and words in the title
or abstract. We combined search terms of exposure
(smoking during pregnancy) with the outcome of the
study (stillbirth). The MeSH terms used included combi-
nations of the terms: stillbirth, maternal smoking, and
pregnancy, also applied with special characters ($, *),
wherever required. The study protocol was agreed withinthe team, however it was not published prior to com-
mencement of the review. We also checked the refer-
ence list of all identified papers and the most recent
similar reviews for any additional studies. A complete
online search strategy along with search terms is attached
(Additional file 1).
Study selection and outcome definition
The electronic search was performed with a three-stage
approach; first titles were screened by TM and AA, then
abstracts were screened by two authors independently
(TM and SL). For studies, which appeared to be eligible,
full texts were obtained and reviewed independently by
two authors who further performed data extraction inde-
pendently on pre-piloted forms, and discrepancies were
resolved by consensus. We also obtained full texts for
those studies where a decision could not be made based
on title and abstract. Data extraction forms included fol-
lowings; study design, exposure validation, definition of
exposure (smoking) and outcome (stillbirth), confounders
adjustments, sample size and study location.
Since stillbirth is defined differently in different coun-
tries and different studies, stillbirth for this review was
defined as fetal loss or death at 20 weeks gestation and
above [20]; this included both early (20-28 weeks gesta-
tion) and late (after 28 weeks) stillbirth enabling inclusion
of a wider range of international studies. Sensitivity ana-
lysis was done using alternative definitions of stillbirth:
a) Stillbirth at ≥ 20 weeks of gestation
b) Stillbirth at ≥ 24 weeks of gestation
c) Stillbirth at ≥ 28 weeks of gestation
Where both unadjusted and adjusted measures were
reported, the latter were extracted. Quality assessment
was based on a Newcastle Ottawa Scale (NOS). Cohort
and case control studies were awarded up to a max-
imum quality score of nine and cross sectional studies
were given up to a maximum score of seven [21]. A def-
inition of ‘high quality’, was given to cohort and case
control studies with a score of 7 or above or cross-
sectional studies with a score of 5 or above; the rest were
deemed ‘low quality’ [21]. Each quality assessment
(NOS) was conducted by at least by two authors inde-
pendently and then findings were verified.
Statistical analysis
Meta-analysis was performed using Rev-Man 5.3 [22]
with a random effects model. The I2 statistic was applied
to calculate heterogeneity (I2 more than 75% was consid-
ered high heterogeneity, more than 50% moderate and
25% was considered as low heterogeneity) [22]. The odds
ratio for the overall effect of smoking in pregnancy from
each study was used, which was the main outcome
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from the available data, wherever feasible. Studies included
in the meta-analysis were further considered for subgroup
analysis based on study quality, definition of stillbirth and
cigarette consumption (1-9 cig/day and ≥10 cig/day). The
funnel plot method was used to assess publication bias.
Studies without statistical data presentation, and those
where cases were potentially overlapping between publica-
tions, were considered in a narrative synthesis.
Results
The initial database search produced 2,934 papers. We
found 1,168 duplicate studies; meaning the same study
was obtained from more than one of the four databases
used in the review. After removal of duplicates, 1,766
study titles were screened, 94 were found eligible for ab-
stract screening and 35 papers were considered for full
text analysis. Out of 35 full texts sought, 34 were ob-
tained within the available research timelines, and of
these, 29 were included in the systematic review
[12-14,16-18,23-45]. Eight full text studies, which did
not have sufficient qualitative or quantitative data rele-
vant to this review, were excluded [46-53]. An additionalFigure 1 Flow diagram of included and excluded studies.five relevant studies [54-58] were identified from refer-
ences listed in the full text eligible studies. Details of the
electronic search are explained in Figure 1. Out of the
34 included studies, 24 were included in the meta-analysis
[12-14,17,23,24,26-29,31-41,54-56] and the other remaining
ten in the qualitative synthesis [16,18,25,30,42-45,57,58].
One of the studies, [23] used two separate study designs,
case control and bidirectional crossover methodology;
therefore the study was considered in the meta-analysis
separately as two observations resulting in 25 studies in-
cluded in the quantitative synthesis. Two studies refer-
ences [30,31] were derived from the same dataset
(Missouri, USA) conducted in the same timeframe (1978-
1997). Study [31] with a higher sample size was included
in the meta-analysis and the other [30] was considered in
the narrative synthesis. Four studies [16,17,25,29] used the
same study population (Swedish National registry data)
with differences in sample size and study methodology.
Studies [17,25] had the same time frame, with study [17]
having a higher sample size. Studies [16,17,29] had over-
lapping but not the exact dataset time frames. Study [16]
time period (1983 – 1985) was exceeded by study 17
(1983-1989) which also had a higher sample size. Study
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poses. To avoid having any woman’s data being counted
twice in the meta-analysis, only the estimates obtained for
1991 data [29] were used in the meta-analysis. Two stud-
ies [17,29] were included in the meta-analysis whilst the
other two studies [16,25] were included in the narrative
synthesis only.
Included studies are further detailed in Table 1.
Out of the 34 eligible studies (Table 1), eight were
case control studies [23-28,54,55], five cross sectional
[16,18,40,41,45] and twenty-one were cohort studies
[12-14,17,29-39,42-44,56-58]. Fourteen were conducted
in Europe, [13,14,16,17,25,27,29,32,36-39,43,54], four in
Australia [34,41,56,58], fourteen in North America
[12,18,23,26,28,30,31,33,35,42,44,45,55,57], one in Asia
[40] and one in South America [24]. The largest sample
size observed was 7,792,990 [45] with the smallest being
202 [25]. Ten studies [13,16,25,26,30-32,35,54,55] did
not present their results with odds ratios but had suffi-
cient data to calculate the ratio using STATA 12, which
was further used in the meta-analysis. Seven studies
[18,42-45,57,58] did not present estimates or sufficient
data to calculate an odds ratio; therefore they were in-
cluded in the narrative synthesis. Based on NOS scale,
overall study quality was moderately satisfactory. Ten co-
hort studies [12,14,17,32,35-39,42] and four case control
studies [23,24,54,55] were considered of high quality with
seven or more points, and only two cross sectional studies
[16,45] were of high quality having five or more points.
Scores ranged from 2 to 9 and the median score was 6.
The type of exposure
Eleven studies clearly defined the level of exposure
(smoking) [14,16,17,25,29,31,33,34,38,54,56]. Most of the
studies used categories of 1-9cig/day and ≥10 cig/day to
categorise participants according to the number of cig-
arettes or packs consumed daily, but the Robson study
[41] used slightly different categories. Seventeen studies
did not define smoking according to level of cigarette con-
sumption [12,13,24,26-28,30,32,35,36,40,41,43,45,55,57,58]
but according to the smoking status (yes/no). Fifteen
studies collected exposure information during pregnancy
[12-14,16,17,27,29,30,32,33,38,42,43,54,56] and the rest
of the studies [18,23-26,31,34,35,39-41,44,45,55,57,58]
obtained the information after delivery. None of the
studies reported biochemical validation of smoking status
such as salivary cotinine assessments.
Data collection on outcome
The definition of stillbirth varied across studies.
Twenty-one out of thirty-four studies included stillbirth
from early gestational age ≥ 20 weeks [18,23,30,31,33,34,
36,37,41-43,45,56-58], ≥22 weeks [54], ≥23 weeks [35],
and four studies used birth weight to estimate thegestational week of stillbirth (Birth weight ≥ 500 g,
[24,26,28,44]. The rest of the studies used late gesta-
tional ages as the cut off values for stillbirth, ≥24 weeks
in four studies [12,13,27,32], ≥28 weeks in nine studies
[14,16,17,25,29,38-40,55]. In all studies, outcome data
was either obtained from medical or clinical records,
medical data sets or birth registry records.
Fourteen studies included in the quantitative synthesis
adjusted for one or more confounders (Table 1). Maternal
age was the most common adjusted factor. Five studies
adjusted for socioeconomic status (SES) including educa-
tion [13,14,37,38,40]. Other factors that were adjusted for
include parity, BMI, ethnicity/race, infant sex, perinatal
care and marital status, alcohol, caffeine intake and co-
habitation. Four studies [24,27,36,39] did not adjust for
any confounders and six studies [26,31,32,35,54,55] had
OR calculated therefore considered as not adjusted for
any confounders. Factors adjusted in cohort studies varied
widely. Several studies [12,17,28,34,37,41,56] considered
one or more medical conditions such as pregnancy com-
plications, diabetes mellitus and hypertension as possible
confounders.
Meta-analysis of maternal smoking and risk of stillbirth
In meta-analysis of all 25 studies (Figure 2), smoking
during pregnancy was associated with a 47% increase in the
odds of stillbirth (OR 1.47, 95% CI 1.37, 1.57, p < 0.0001)
with an overall moderate heterogeneity (I2 = 79%). There
was no significant difference in the size of this estimate
between study designs (p = 0.11); the odds of stillbirth
were increased by 34% in relation to smoking in preg-
nancy in case-control studies (OR 1.34, 95% CI 1.23, 1.45,
p < 0.0001, 8 studies), 49% in cohort studies (OR 1.49, 95%
CI 1.35, 1.64, p < 0.0001, 15 studies) and 62% in cross-
sectional studies (OR 1.62, 95% CI 1.31, 2.00, p < 0.0001, 2
studies). Results were more heterogeneous for cohort
studies than other study types.
Subgroup analysis by study quality
Results from high quality score studies showed that
women who smoke during pregnancy, are 41% more
likely to have a stillbirth compared to women who do
not smoke during pregnancy (OR 1.41, 95% CI 1.28,
1.55, p <0.0001, 14 studies). Low quality score studies
showed that women who smoke during pregnancy were
at 49% increased odds of stillbirth compared to women
who do not smoke during pregnancy (OR 1.49, 95% CI
1.33, 1.67, p <0.0001, 11 studies). There was no signifi-
cant difference between the two subgroups (p = 0.44).
Subgroup analysis by categories of cigarette consumption
Seven studies (14, 26 a-b,31,34,45,48) were included in
this subgroup analysis, with consumption categorised as
1-9 cig/day and ≥10 cig/day (Figure 3). One study [29]
Table 1 Table of included studies
Reference Author
year
Study
type
Population Location Exposure:
smoking during
pregnancy and
validity
Definition of stillbirth
(outcome) and
gestational period
Estimates Factors adjusted for in individual
studies if available
Studies included in meta-analysis
12 Wood et al
(2009)
Cohort 158,502 Alberta Perinatal Health
Program, 1991-2004
Canada
Smokers: Yes Fetal death after at least
24 completed weeks of
gestation.
Adjusted OR 1.04 (0.74-1.47) Maternal age, diabetes, hypertension,
previous caesarean section.
Not validated
13 Smith et al
(2007)
Cohort 84,769 Scotland morbidity
records 1991-2001, UK
Smokers: Yes Fetal death after at least 24
completed weeks of
gestation.
OR for smoking was calculated
2.15 (95% CI 1.74-2.65)
Age, deprivation, height, BMI, Marital
Status.
Not validated
14 Hogberg
and
Cnattingius
(2007)
Cohort 526,691 Sweden – Swedish
National study 1983-
2001- Participants with
two consecutive
pregnancies.
Smokers: Yes Fetal death after at least 28
completed weeks of
gestation.
OR for smoking in both Pregnancies
1.35 (1.15-1.58). 1-9cig/day OR 1.16
(0.92-1.46) ≥10 cig/day 0R 1.55
(1.17-2.04). OR for smoking in the
1st pregnancy only OR 1.02 (0.79-
1.30), 1-9 cig/day OR 1.13 (0.9-1.39),
≥10 cig/day OR 1.14 (0.87-1.51). OR
for smoking in 2nd pregnancy only
0.84 (0.55-1.26), 1-9cig/day OR 1.10
(0.89-1.35), ≥ 10 cig/day OR 1.45
(1.16-1.81).
Maternal age, education, cohabiting
with infant’s father, mother’s country
of birth, year of second delivery,
inter-pregnancy interval and stillbirth
in first pregnancy.
1-9 cig/day, ≥10
cig/day.
Not validated
26 Salihu et al
(2008)
Case
control
1,444,378 USA – Missouri 1978-
1997.
Smokers: Yes In-utero fetal death at least
20 week into gestation.
a) Bidirectional case cross-over
OR 1.20 (1.03-1.39) 1-9 cig/day OR
1.16 (0.88-1.53) 10-19 cig/day OR
1.10 (0.90-1.24) ≥ 20 cig/day OR
1.21 (1.01-1.50),
Maternal race and age.
1-9 cig/day,
10-19 cig/day, b) Case Control OR 1.34 (1.26-1.43)
1-9 cig/day OR 0.94 (0.76-1.70)
10-19 cig/day OR 1.31(1.22-1.41)
≥20 cig/day OR 1.43 (1.31-1.54).
≥20 cig/day.
Not validated
34*** Ahlenius
and
Thomassen
(1999)
Cohort 94,270 in
1984 and
124,201 in
1991.
Sweden - Using the
Swedish medical birth
register in 1984 and
1991
Smokers: Yes. Death of a fetus before or
during delivery with a
gestational duration of at
least 28 weeks.
Combined (1984 and 1991) OR
1.37 (1.17 to 1.61)
Maternal age and parity.
1-9 cig/day, ≥10
cig/day.
1-9 Cig/day OR 1.22
(1.00-1.48)
Not validated ≥10 Cig/day OR 1.62 (1.31-2.00)
1991 OR
1.47 (1.19 to 1.82)
>10 Cig/day OR 1.97 (1.51-2.59)
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36*** Aliyu et al
(2007)
Cohort 1,436, 725 USA Missouri – Using
Missouri maternally
linked cohort data
1978 – 1997
Smokers: Yes In utero fetal death
at < = 20 weeks gestation
OR(originally presented as HRs)
1.43 (1.36-1.51)
N/A*
1-9 cig/day,
10-19 cig/day,
≥ 20 cig/day.
Not validated
37 Gray et al
(2009)
Cohort 532,016 UK- Scotland, National
study 1994-2003.
Smokers: Yes. 24-44 weeks’ gestation OR 1.75 (1.61-1.91) N/A*
Not validated
38 McCowan
et al (2007)
Cohort 69,173 New Zealand - National
Women’s
Smokers: Yes Birth of a baby with no
signs of life delivered at ≥
OR 1.33 (0.99-1.79) Infant sex, maternal ethnicity, parity,
marital status, maternal age at
delivery, history of previous
miscarriage, history of previous
abortion, previous low-birth weight
infant, previous C-section.
Hospital, Auckland, New
Zealand from 1993 to
2000
Not validated 20 weeks or with a birth
weight of > 400 g if
gestation was not known.
39 Miller et al
(2010)
Cohort 359,747 Canada – Ontario state
2004-2006
Smokers: Yes Death of fetus at 20 weeks
of gestation
Overall OR 1.58 (1.38-1.81) Age, parity, multiple gestation
Not validated
40 Moshin et
al (2005)
Cohort 433,227 Australia – New South
Wales 1998-2002
Smokers: Yes Fetal death at≥ 20 weeks
gestation or of 400 g or
more birth weight.
Overall adjusted OR 1.17
(1.05–1.31) Unadjusted
OR 1.05 (0.94–1.17).
Maternal age, maternal country of
birth, socioeconomic status, maternal
diabetes mellitus, and first antenatal
care visit.
Not validated
17*** Raymond
et al (1994)
Cohort 638,242 Sweden National study
1983-1989
Smokers: Yes Fetus death at 28 weeks of
gestation or more.
OR 1.4 (1.2-1.4) Age, parity, pregnancy complications,
hypertensive diseases, diabetes, placental
complications and intrauterine growth
retardation (IUGR).
Not validated
42 Reddy et al
(2006)
Cohort 174,809 USA – 12 clinic centres
and 19 hospital sites.
2002-2008.
Smokers: Yes Fetal death at 23 weeks
gestation and beyond.
OR (originally presented as HRs)
1.57 (1.21-2.02)
N/A*
Not validated
43 Sutan et al
(2010)
Cohort 541,811 UK- Scotland, National
study (NHS Hospital)
Smokers: Yes Late fetal death from
20 weeks gestation.
OR 1.64 (1.46-1.84) Non stated
Not validated
44 Tuthill et al
(1999)
Cohort 16,047 Wales – All Wales
Perinatal Survey
1993-1995
Smokers: Yes Mortality from 20
completed weeks of
gestation
OR 1.72(1.38-2.13) Social class, infection, placental
abruption, sudden infant death
syndrome.Not validated
45 Wisborg et
al (2001)
Cohort 25,102 Denmark – Aarhust
University Hospital
1989-1996.
Smokers: Yes Delivery of a dead fetus
occurring at 28 weeks or
more gestation.
OR 1.9 (1.3-2.9), Sex of child, parity, maternal age,
education, alcohol, caffeine intake.
1-9 cig/day, ≥10
cig/day.
1-9 cig/day OR 1.5 (0.9-2.4) ≥10
cig/day 1.8 (1.2-2.8)
Not validated
46 Winbo et al
(2001)
Cohort 1,412,747 Sweden – National
study 1983 - 1995
Smokers: Yes Death of fetus after
competing 28 weeks of
gestation.
OR stillbirths ≥37 weeks
compared with live births 1.08
(0.96-1.22)
Non stated
Not validated
27 Ferraz and
Gray (1991)
Case
control
11,483 Brazil – Natal city and
state of Rio Grande do
Norte 1984-1986
Smokers: Yes Stillborn cases weighing
500 g or more
OR 1.4 (1.0-2.0) Non stated
Not validated
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29 Dodds et al
(2006)
Case
control
494 Canada – Nova Scotia
and Eastern Ontario
1999-2001
Smokers: Yes Not specified - Death
before delivery of a fetus
weighing 500 g or more
OR (originally presented in HRs)
Smoking during 1st trimester 2.13
(1.23-3.64)
N/A*
Not validated
30 Efkarpidis et
al (2004)
Case
control
599 UK – Nottingham City
Hospital 1991-1997.
Smokers: Yes Definition of stillbirth not
stated- pregnancies
considered from ≥ 24 weeks
OR 1.2 (0.64-1.6) Non stated
Not validated
31 Froen et al
(2002)
Case
control
598 Norway – Oslo
1986-1995.
Smokers: Yes Intrauterine death before
onset of labour of a
fetus > =22 weeks gestation
or > = 500 g body mass
OR calculated Using Stats 1.81
(1.02-3.15) 1-9 cig/day OR 1.0
(0.43-2.12), ≥10 cig/day 0R 3.04
(1.13-8.19)
N/A*
1-9 cig/day,
≥10 cig/day.
Not validated
32 Goy et al
(2008)
Case
control
510 Canada – Nova Scotia
and Eastern Ontario
1999-2001.
Smokers: Yes Not specified - Death
before delivery of a fetus
weighing 500 g or more
OR 2.06 (1.22-3.47) Province of origin, age, inactivity
during pregnancy, stillbirth in
previous pregnancy, used fertility
treatment
Not validated
33 Little and
Weiberg
(1993)
Case
control
4667 USA Smokers: Yes Fetal death at 28 weeks
or more gestation
OR calculated using Stata 1.29
(1.09-1.53)
N/A*
1-19 cig/day, OR 1-19 cig/day 1.3 (1.09-1.57),
20-29 cig/day OR 1.39 (1.06-1.82),
≥30 cig/day OR 0.67 (0.41-1.12).20-29 cig/day,
≥ 30 cig/day.
Not validated
47 Mishra et al
(2005)
Cross-
sectional
16,802 India - Survey
conducted 98-99
Smokers: Yes Delivery of a dead baby
at > 28 weeks of pregnancy
OR 1.23 (0.92-1.64) Cooking smoke, anaemia, BMI,
education, standard of living, house
type.Not validated Unadjusted OR 1.60 (1.23-2.08).
48 Robson et
al (2006)
Cross-
sectional
21, 880 Australia – New South
Wales 1998-2003.
Smokers: Yes Not stated OR 1.65 (1.15-2.38) Age, parity, medical/obstetric
complications
1-10 cig/day
>10 cig/day.
20 weeks 1- 10 cig/day OR 1.16 (0.80-1.69)
>10 cig/day OR 1.68 (1.17-2.41).
Not validated
Studies included in narrative synthesis
16*** Cnattingius
et al (1988)
Cross-
sectional
262,582 Sweden National
Study – Using Swedish
medical birth registry
covering more than 99%
of all births in Sweden.
1983-1985
Smokers: Yes Late fetal death – still birth
occurring at 28 weeks of
gestation or later
OR (originally presented as RR)
1.37 (1.20-1.57)
N/A*
1-9 cig/day, 1-9 cig/day 1.32 (1.12-1.55)
≥10 cig/day. ≥10 cig/day 1.45 (1.21-1.75)
Not validated
28*** Walles
(1994)
Case
control
202 Sweden – 5 centres
(Boras, Helsingborg,
Karlskrona,
Kristianstastad and
Lund) 1983-1989.
Smokers: Yes Definition of stillbirth not
stated, pregnancies
considered
OR calculated using Stata. OR 1.18
(0.62-2.26)
N/A*
1-10 cig/day, 1-10 cig/day OR 1.33 (0.58-3.09)
>10 cig/day 1. 04 (0.43-2.50)
≥10 cig/day. ≥ 28 weeks
Not validated
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Table 1 Table of included studies (Continued)
35*** Aliyu et al
(2008)
Cohort 1,436,628 USA Missouri – Using
Missouri maternally
linked cohort data
1978 – 1997.
Smokers: Yes. In utero fetal death at < =
20 weeks gestation.
OR (originally presented as HRs)
1.48 (1.40-1.56)
N/A**
< 35 years old,
≥ 35yers old.
Not validated
< 35 years smokers1.43 (1.35-1.51)
≥35 years Smokers OR
2.4 (2.06-2.80)
49 Kleinman et
al (1988)
Cohort 362,261 USA Missouri 1978-1983 Smokers: Yes (Fetal mortality) Fetal death
at 20 weeks or more.
OR Primiparas N/A**
< 1 pack/day
≥1 pack/day.
<1 pack/day 1.36(1.16-1.59)
≥1 pack/day 1.62 (1.34-1.97)
Not validated Multiparas
<1 pack/day 1.21 (1.06-1.38)
≥1pack/day 1.15(0.99-1.34)
50 Raatikainen
et al (2006)
Cohort 25,591 Finland-Kuopio University
Hospital 1989-2001.
Smokers: Yes. Fetal death was defined as
intrauterine death before
No estimates N/A**
Not validated
22 weeks of pregnancy or
500 g fetal weight.
51 Aliyu et al
(2010)
Cohort 633,849 US Missouri – Using
Missouri maternally-
linked cohort data files
1978 – 1997.
Smokers: Yes In utero fetal death at > =
20 weeks gestation.
Results HRs, N/A**
Not validated <15 years 3.3 (1.4-7.8), 15-19 years
1.7 (1.5-1.9), 20-24 years
1.5 (1.4-1.6)
No sufficient data to calculate
Odds ratios.
52 Bai et al
(2000)
Cohort 7138 Australia- Liverpool
hospital Sydney March
1996 to June 1998
Smokers: Yes Not Clear (births occurring
at less than 20 weeks
gestation age exclusion
criteria).
Results presented in Percentages.
No odds ratios and no sufficient
data to calculate OR.
N/A**
Not validated
53 Huang et al
(2000)
Cohort 84,294 Canada – The Royal
Victoria Hospital in
Montreal 1961-1974
and 1978-1996.
Smokers: Yes Fetal deaths occurring
before labour without
evidence of significant fetal,
maternal or placental
pathology weighing 500 g
or more.
No estimates N/A**
Not validated
18 Schramm
(1997)
Cross-
sectional
176,843 USA – Missouri
1978-1990
Smokers: Yes Not
validated
Fetal death greater or equal
to 20 weeks gestation.
Results in RR no sufficient data to
calculate OR
N/A**
Smoking in 1st and not in 2nd
pregnancy RR 1.11, Not smoking
in 1st but in 2nd pregnancy RR
1.6.smoking in both pregnancies
RR 1.19.
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Table 1 Table of included studies (Continued)
54 Salihu et al
(2004)
Cross-
sectional
7,792,990 USA – 1995-1997. Smokers: Yes Intrauterine fetal demise
after 20 weeks of gestation.
Estimates in Hazard ratios not
enough data to calculate OR.
N/A**
Not validated ≥ 40 years 2.71 (1.88-3.91), 30-39
years 1.58 (0.96-2.60), 20-29 years
1.41 (1.16-1.71)
OR – Odds Ratio, HR – Hazard Ratio, RR – Risk Ratio.
N/A* - Original results were presented in HR/RR, OR was calculated using original data.
N/A** - Studies included in descriptive synthesis only.
*** - Studies using same dataset.
Swedish National registry data set ref 16: 1933-1985, 17 and 28 : 1983-1989, ref 34: 1984 and1991.
US – Missouri data set ref 35 and 36.
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Figure 2 Maternal smoking in pregnancy and the risk of stillbirth.
Marufu et al. BMC Public Health  (2015) 15:239 Page 10 of 15presented OR values for the ≥10 cig/day category only.
A study by Robson et al [41] used slightly different cat-
egories; 1-10 cig/day and >10 cig/day. This study was in-
cluded in this analysis with odds ratios for the 1-10 cig/
day, and > 10 cig/day categories used for the 1-9 cig/day
and ≥ 10 cig/day groups respectively. Further two studies
by Salihu et al (2008a) [23] and Salihu et al (2008b) [23]
had a classification of 1-9 cig/day, 10-19 cig/day and ≥ 20
cig/day. There was no sufficient raw data to calculate the
OR for ≥10 cig/day. Therefore these studies have been in-
cluded in this analysis conservatively using the ORs from
the 10-19 cig/day categories (which is a lower value than
the ≥ 20 cig/day value) for the ≥ 10 cig/day subgroup. Most
of the studies included in this subgroup analysis (4 out of7) used this categorisation (1-9 cig/day and ≥10 cig/day),
thus the same was applied in the subgroup analysis. Meta-
analysis showed that smoking 1-9 cig/day was associated
with an 9% increased odds of having a stillbirth compared
to women who do not smoke in pregnancy (OR 1.09, 95%
CI 1.09, 1.24, p = 0.55, 6 studies), whilst smoking ≥10 cig/
day was associated with a 52% increase in odds of stillbirth
(OR 1.52, 95% CI 1.30, 1.78, p < 0.0001, 7studies); the
results for these two subgroups differed significantly
(p = 0.001).
Subgroup analysis by gestation of stillbirth
Twenty-two studies were included in this subgroup ana-
lysis (Figure 4). The meta-analysis of studies defining
Figure 3 Stillbirth risk according to the amount of daily cigarette consumption.
Marufu et al. BMC Public Health  (2015) 15:239 Page 11 of 15stillbirth at ≥ 20 weeks demonstrated a 43% increase in
odds for smoking mothers compared to mothers who do
not smoke, (OR 1.43, 95% CI 1.32, 1.54, p < 0.0001, 11
studies), whereas studies with stillbirth defined at ≥
24 weeks showed 58% increase in odds (OR 1.58, 95%Figure 4 Maternal smoking and the risk of stillbirth according to theCI 1.21, 1.2.06, p < 0.0003, 4 studies) and in pooled esti-
mates of studies with stillbirth defined at ≥ 28 weeks, the
odds was increased to 33% (OR 1.33, 95% CI 1.18, 1.49,
p < 0.02, 7 studies). There was no significant difference
in the odds ratios for these different subgroups (p = 0.39).gestation period.
Table 2 Result summary: maternal smoking in pregnancy
and the risk of stillbirth
Assessment criteria Odds ratio 95% CI
i) Overall pooled Results from main
meta-analysis (25 studies)
1.47 1.37-1.57
ii) Subgroup analysis by daily amount of
cigarettes consumption
1-9 cig/day (6 studies) 1.09 0.97-1.24
≥ 10 cig/day (7 studies) 1.52 1.30-1.78
iii) Subgroup analysis by gestation period at
which stillbirth occurred
Stillbirth ≥ 20 weeks (11 studies) 1.43 1.32-1.54
Stillbirth ≥ 24 week (4 studies) 1.58 1.21-2.06
Stillbirth ≥ 28 weeks (7 studies) 1.33 1.18-1.49
iv) Subgroup analysis by geographic location
North America (9 studies) 1.39 1.29-1.50
Europe (11 studies) 1.55 1.36-1.78
Asia (1 study) 1.23 0.92-1.64
South America (1 study) 1.40 1.00-1.96
Australia (3 studies) 1.29 1.07-1.55
v) Subgroup analysis by quality
High score (14 studies) 1.41 1.28-1.55
Low score (11 studies) 1.49 1.33-1.67
Marufu et al. BMC Public Health  (2015) 15:239 Page 12 of 15Subgroup analysis by study location
Only two studies were conducted in developing countries
[24,40]. Both studies support evidence from research con-
ducted in developed countries concluding that women
who smoke during pregnancy are at a risk of stillbirth. A
study [40] demonstrated a very marginal difference show-
ing those women who smoke during pregnancy are at
least 40% at risk of experiencing a stillbirth (OR 1.40, 95%
CI 1.0, 1.96), similar to the pooled odds ratio of studies
conducted in North America (OR 1.39, 95% CI 1.29, 1.50)
P value < 0.0001, 9 studies) and Europe (OR 1.55, 95% CI
1.36, 1.78, P value < 0.0001,11 studies).
Narrative synthesis
Seven studies [18,42-45,57,58] presented their results in
other than odds ratio and there was no sufficient data to
calculate the odds ratio, and three studies [16,25,30]
were derived from same study population as [17,31] re-
spectively. Six of the studies [16,18,30,42,45,57] observed
an association between maternal smoking in pregnancy
and the risk of stillbirth but the other four [25,43,44,58]
observed no significant differences. Two studies [16,42]
observed a dose related response with high risk ratio of
stillbirth in mothers who smoke ≥10 cig/day compared
to 1-9 cig/day and those who smoke ≥1 pack/day in con-
trast to <1 pack/day respectively. Three studies (51, 35
54) showed the risk of stillbirth to be higher in young
mothers <15 years old (HR 3.3, 95% CI 1.4, 7.8) and also
in older mothers (≥35 years, HR 3.2, 95% CI 2.2, 4.5)
(≥40 years, HR 2.71, 95% CI 1.88, 3.91) respectively. A
study from Sweden suggested that placental abruption is
likely to be common in smokers [25].
Publication bias
The publication bias was assessed visually using a funnel
plot developed by Rev Man 5.3 [22]. The plot was
symmetrical indicating a low risk of publication bias
(Additional file 2).
Discussion
This study provides a comprehensive review of the
current evidence and estimates of the effect of maternal
smoking on the risk of stillbirth. It suggests, women
who smoke during pregnancy have a 47% increased risk
of stillbirth and that the risk of stillbirth is more at
higher levels of cigarette consumption (Table 2). This ef-
fect does not vary according to the gestation at which
still birth occurs, however, comparisons between studies
would be easier if future work adopted the definition of
stillbirth recommended by the WHO [20].
Strengths and limitations
We implemented a comprehensive search strategy with
strict adherence to the protocol, and results werepresented in accordance with MOOSE guidelines [19].
Search strategy, data extraction, analysis and quality
assessment was performed independently by authors
and findings were confirmed within the team. There
was no evidence of publication bias. However, the re-
view has some limitations. We could not obtain one
study within available timelines [59], and due to lim-
ited data presentation, seven studies [18,42-45,57,58]
were considered in the narrative synthesis. Secondly,
only English language studies were considered mainly
for practical purposes and the available timeframe.
Heterogeneity was explored using a variety of subgroup
analyses; a high level of heterogeneity was found amongst
cohort studies and the pooled estimate derived from these
should be treated with some caution. This could be par-
tially attributable to the different factors controlled for in
the cohort studies as explained previously. The overall
heterogeneity (I2 = 77%, Figure 2) was higher mainly due
to cohort studies, however in case of case control studies
(I2 = 20%) and cross-sectional studies (I2 = 0%), very low
levels of heterogeneity was observed. However, this esti-
mate was consistent with synthesised estimates derived
from studies with other designs and this consistency sug-
gests it is likely to be valid. It appears that the effect could
differ by age [24,30,38,45,57], but data on maternal age
was not available in included studies. Study quality was
found to be satisfactory.
Marufu et al. BMC Public Health  (2015) 15:239 Page 13 of 15Synthesis
The most recent systematic review by Flenady et al [8]
on maternal smoking and the risk of stillbirth, focusing
on high-income countries, reported a 36% increase in
the odds of stillbirth (OR 1.36). The review considered
cohort and case control studies published between 1998
and 2009 and excluded those which did not control for
confounding factors, hospital based studies and took a
slightly different approach to dealing with duplicate
studies. Acknowledging the difference in the approach,
our study is in agreement with the results from Flenady’s
et al [8] review, and showed a 46% increased risk of still-
birth (OR 1.46 95% CI 1.36, 1.55). We included 25 stud-
ies in our main meta-analysis, conducted in both
developing and developed countries making our findings
generalisable. Our review has also analysed the available
data according to the definition of stillbirth in gesta-
tional weeks, number of cigarettes and study quality,
which were not reported in the previous published lit-
erature. The review also provides strong evidence that
the risk is higher at higher levels of cigarette consump-
tion, indicating a dose related response relationship, out-
lined in some of the included studies [15,38,42].
The consistency in the size of the effect observed in
this study throughout different subgroup analyses and
across different study designs, each with their own biases
and strengths and limitations, as well as the consistency
across studies of differing quality, suggests that this is a
true estimate of the size of effect. Further support is ob-
tained from studies where mothers change in smoking
behaviour from one pregnancy to another. Hogberg and
Cnattingius [14] suggested that mothers who quit smok-
ing from first to second pregnancy reduced their risk of
stillbirth to the same level as non-smokers in both preg-
nancies, while those who smoked in both pregnancies
had a 35% increased risk of stillbirth (OR 1.35) com-
pared to non-smokers.
Our results also provide evidence that the effect of
maternal smoking in pregnancy on risk of stillbirth is
not dependent on the definition of stillbirth or on the
stage of pregnancy at which it occurs. Moreover we did
not ascertain, at what point during pregnancy the effect
of the exposure is occurring as most studies evaluated
the exposure at one point in time only. Previous studies
[26,38] suggested that the timing of exposure may in-
fluence the risk of stillbirth and in particular [38] sug-
gested that those who quite early in pregnancy may
have similar risk to non-smokers. Future studies of this
association should measure exposure at different stages
of gestation. There are important potential con-
founders for the effect of maternal smoking on risk of
stillbirth, the most important ones are SES, maternal
age, maternal weight and medical comorbidities, ma-
jority of studies have adjusted for these. Only twostudies did not adjust for any confounders [36,43] with
no further information.
The exact pathophysiology of fetal exposure to tobacco
smoke is not entirely understood, however based on
available evidence, possible mechanisms have been con-
ceptualised [30]. Nicotine has been known to cause nar-
rowing of the placental vessels [60,61], which coupled
with reduced prostacycline synthesis [62], resulting in
increased vascular resistance and consequently impairing
blood supply to the fetus [63]. Carbon monoxide in to-
bacco smoke also reduces fetal oxygenation by forming
carboxy-haemoglobin in turn interfering with oxygen-
ation transfer [64]. The correlation between smoking
and stillbirth is likely to be explained through increased
prevalence of placental complications and fetal growth
restriction [14]. The resultant physiological effect of
these changes increases the risk of fetal morbidity (small
for gestation age and preterm birth) and subsequently
may lead to fetal death [30]. Therefore, there is strong
biological plausibility for smoking in pregnancy causing
stillbirth [46,65].
Recent Cochrane reviews have concluded that behav-
ioural interventions can be effective in helping women
to stop smoking in pregnancy [66] even though there re-
mains no evidence for the effectiveness of pharmaco-
therapy such as NRT in pregnancy [67]. The result of
our study suggests that such interventions are important
to reduce the risk of stillbirth.
Conclusion
Our findings support that smoking greatly increases the
risk of stillbirth. Smoking in pregnancy is an established
cause of a range of pregnancy complications and poor
pregnancy outcomes. Every opportunity must be utilised
to record smoking status during pregnancy, to give ad-
vice and support, including necessary facilities to help
women stop smoking. Although we have conducted a
comprehensive review, most of the available evidence on
the risk from smoking is from developed countries.
Smoking is rapidly increasing in the developing world
where stillbirth is a major problem; therefore along with
focusing on research initiatives, it is important to invest
efforts on educating women on the risks of smoking to
their unborn child and providing smoking cessation sup-
port for pregnant women in these parts of world.
Additional files
Additional file 1: Supplementary 1. Sample search strategy used for
identification of studies.
Additional file 2: Funnel plot.
Abbreviations
NOS: New castle Ottawa scale; SES: Socioeconomic status.
Marufu et al. BMC Public Health  (2015) 15:239 Page 14 of 15Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The study was conceptualised by SL, TC, TM and AA. All authors participated
in electronic search, title screening, study selection, data extraction, analysis
and manuscript preparation. AA and TM contributed equally in the
manuscript preparation, and thus shared the first authorship equally. All four
authors provided intellectual content and approved the manuscript for
publication.
Acknowledgments
We acknowledge the support of the Greenfield Medical Library staff of
University of Nottingham, UK.
Author details
1Division of Epidemiology and Public Health, Faculty of Medicine and Health
Sciences, University of Nottingham, Clinical Sciences Building 2, Nottingham
City Hospital, Hucknall Road, Nottingham NG5 1 PB, UK. 2Halo Medical
Foundation, Osmanabad, India. 3Division of Primary Care, Faculty of Medicine
and Health Sciences, University of Nottingham, Nottingham, UK.
Received: 24 October 2014 Accepted: 16 February 2015
References
1. World Health Organisation (WHO). Recommendations for the prevention
and management of tobacco use and second- hand smoke exposure in
pregnancy. Geneva: World Health Organization; 2013.
2. Royal College of Physicians. Passive smoking and children: a report of the
Tobacco Advisory Group of the Royal College of Physicians. London: Royal
College of Physicians; 2013.
3. Royal College of Physicians. Smoking and the young. London: Royal college
of Physicians; 1992.
4. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Pre-pregnancy
weight and the risk of adverse pregnancy outcomes. N Eng J Med.
1998;338:147–52.
5. Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol.
2005;193:1923–35.
6. Lawn JE, Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, et al.
Stillbirths: Where? When? Why? How to make the data count? Lancet.
2011;377:1448–63.
7. Cnattingius S. The epidemiology of smoking during pregnancy: smoking
prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob
Res. 2004;6:S125–40.
8. Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, Gibbons K, et al.
Major risk factors for stillbirth in high-income countries: a systematic review
and meta-analysis. Lancet. 2011;377:1331–40.
9. NHS Information centre. The Infant Feeding Survey 2010. Available at
http://www.hscic.gov.uk [Accessed January 2013].
10. Scollo MM, Winstanley MH. Tobacco in Australia: Facts and issues. 4th ed.
Melbourne: Cancer Council Victoria; 2012. Available from
www.TobaccoInAustralia.org.au.
11. Ebert LM, Fahy K. Why do women continue to smoke in pregnancy?
Women Birth. 2007;20:161–8.
12. Wood SL, Chen S, Ross S, Sauve R. The risk of unexplained antepartum
stillbirth in second pregnancies following caesarean section in the first
pregnancy. BJOG. 2008;115:726–31.
13. Smith GCS, Shah I, White IR, Pell JP, Crossley JA, Dobbie R. Maternal and
biochemical predictors of antepartum stillbirth among nulliparous women
in relation to gestational age of fetal death. BJOG. 2007;114:705–14.
14. Hogberg L, Cnattingius S. The influence of maternal smoking habits on
the risk of subsequent stillbirth: Is there a causal relation? BJOG.
2007;114:699–704.
15. United States Department of Health and Human Services (USDHHS). Health
Consequences of Tobacco use among women. In: Women and smoking: a
report of the surgeon general. Rockville MD: U.S: Department of Health and
Human Services, Centre for Disease Control and Prevention, National Centre
for Chronic Disease Prevention and Health Promotion, Office of Smoking
and Health; 2001. p. 177–450.16. Cnattingius S, Haglund B, Meirik O. Cigarette smoking as risk factor for late
fetal and early neonatal death. BMJ. 1988;297:258–61.
17. Raymond EG, Cnattingius S, Kiely JL. Effects of maternal age, parity and
smoking on the risk of stillbirth. BJOG. 1994;101:301–6.
18. Schramm WF. Smoking during pregnancy: Missouri longitudinal study.
Paediatr Perinat Epidemiol. 1997;11:73–83.
19. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al.
Meta-analysis of observational studies in epidemiology: a proposal for
reporting. JAMA. 2000;283:1–5.
20. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R,
Nygren K, et al. The International Committee for Monitoring Assisted
Reproductive Technology (ICMART) and the World Health Organization
(WHO) Revised Glossary on ART Terminology. Hum Reprod. 2009;24:2683–7.
21. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Newcastle-
Ottawa scale (NOS) for assessing the quality of non-randomised studies in
meta-analysis. Available from: http://www.ohri.ca/programs/clinical_
epidemiology/oxford.htm (accessed March 10, 2012).
22. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews
of Interventions Version 5.1.0 [updated March 2011]. The Cochrane
Collaboration 2011. Available from www.cochrane-handbook.org.
23. Salihu HM, Sharma PP, Getahun D, Hedaytzadeh M, Peters S, Kirby RS, et al.
Prenatal tobacco use and risk of stillbirth: a case-control and bidirectional
case-crossover study. Nicotine Tob Res. 2008;10:159–66.
24. Ferraz EM, Gray RH. A case-control study of stillbirths in Northeast Brazil. Int
J Gynaecol Obstet. 1991;34:3–19.
25. Walles B, Tyden T, Herbst A, Ljungblad U, Rydhstrom H. Maternal health-care
program and makers for late fetal death. Acta Obstet Gynecol Scand.
1994;73:773–8.
26. Dodds L, King WD, Fell DB, Armson BA, Allen A, Nimrod C. Stillbirth risk
factors according to timing of exposure. Ann Epidemiol. 2006;16:607–13.
27. Efkarpidis S, Alexopoulos E, Kean L, Liu D, Fay T. Case-control study of factors
associated with intrauterine fetal deaths. MedGenMed. 2004;6:53.
28. Goy J, Dodds L, Rosenberg MW, King W. Health-risk behaviours: examining
social disparities in the occurrence of stillbirth. Paediatr Perinat Epidemiol.
2008;22:314–20.
29. Ahlenius I, Thomassen P. The changing panorama of late fetal death
in Sweden between 1984 and 1991. Acta Obstet Gynecol Scand.
1999;78:408–14.
30. Aliyu MH, Salihu HM, Wilson RE, Alio AP, Kirby RS. The risk of intrapartum
stillbirth among smokers of advanced maternal age. Arch Gynecol Obstet.
2008;278:39–45.
31. Aliyu MH, Salihu HM, Wilson RE, Kirby RS. Prenatal smoking and risk of
intrapartum stillbirth. Arch Environ Occup Health. 2007;62:87–92.
32. Gray R, Bonellie SR, Chalmers J, Greer I, Jarvis S, Kurinczuk JJ, et al.
Contribution of smoking during pregnancy to inequalities in stillbirth and
infant death in Scotland 1994-2003: retrospective population based study
using hospital maternity records. BMJ. 2009;339:b3754.
33. Miller EC, Cao HL, Wen SW, Yang Q, Lafleche J, Walker M. The risk of
adverse pregnancy outcomes is increased in preeclamptic women who
smoke compared with nonpreeclamptic women who do not smoke. Am J
Obstet Gynecol. 2010;203:1–8.
34. Mohsin M, Bauman AE, Jalaludin B. The influence of antenatal and maternal
factors on stillbirths and neonatal deaths in New South Wales. J Biosoc Sci.
2006;38:643–57.
35. Reddy UM, Laughon SK, Sun L, Troendle J, Willinger M, Zhang J.
Prepregnancy risk factors for antepartum stillbirth in the United States.
Obstet Gynecol. 2010;116:1119–26.
36. Sutan R, Campbell D, Prescott GJ, Smith WCS. The risk factors for
unexplained antepartum stillbirths in Scotland, 1994 to 2003. J Perinatol.
2010;30:311–8.
37. Tuthill DP, Stewart AH, Coles EC, Andrews J, Cartidge PH. Maternal
cigarette smoking and pregnancy outcome. Paediatr Perinat
Epidemiol. 1999;13:245–53.
38. Wisborg K, Kesmodel U, Henriksen TB, Olsen SF, Secher NJ. Exposure to
tobacco smoke in utero and the risk of stillbirth and death in the first year
of life. Am J Epidemiol. 2001;154:322–7.
39. Winbo I, Serenius F, Dahlquist G, Kallen B. Maternal risk factors for
cause-specific stillbirth and neonatal death. Acta Obstet Gynecol
Scand. 2001;80:235–44.
40. Mishra V, Retherford RD, Smith KR. Cooking smoke and tobacco smoke as
risk factors for stillbirth. Int J Environ Health Res. 2005;15:397–410.
Marufu et al. BMC Public Health  (2015) 15:239 Page 15 of 1541. Robson S, Cameron CA, Roberts CL. Birth outcomes for teenage women in
New South Wales, 1998-2003. Aust N Z J Obstet Gynaecol. 2006;46:305–10.
42. Kleinman JC, Pierre MB, Madans Jr JH, Land GH, Schramm WF. The effects of
maternal smoking on fetal and infant mortality. Am J Epidemiol.
1988;127:274–82.
43. Raatikainen K, Huurinainen P, Heinonen S. Smoking in early gestation or
through pregnancy: a decision crucial to pregnancy outcome. Prev Med.
2007;44:59–63.
44. Huang DY, Usher RH, Kramer MS, Yang H, Morin L, Fretts RC. Determinants
of unexplained antepartum fetal deaths. Obstet Gynecol. 2000;95:215–21.
45. Salihu HM, Shumpert MN, Aliyu MH, Alexander MR, Kirby RS, Alexander GR.
Stillbirths and infant deaths associated with maternal smoking among
mothers aged not greater than or equal to 40 years: a population study.
Am J Perinatol. 2004;21:121–9.
46. Moga M, Preda GH. Smoking and pregnancy. J Environ Prot Ecol.
2008;9:566–73.
47. Bukowski R, Carpenter M, Conway D, Coustan D, Dudley DJ, Goldenberg RL,
et al. Association between stillbirth and risk factors known at pregnancy
confirmation. JAMA. 2011;306:2469–79.
48. Kunzel W, Misselwitz B. Unexpected fetal death during pregnancy – a
problem of unrecognised fetal disorders during antenatal care? Eur J Obstet
Gynecol Reprod Biol. 2003;110:S86–92.
49. Xu B, Jarvelin MR, Rantakallio P. Maternal smoking in pregnancy and sex
differences in perinatal death between boys and girls. Soc Biol.
1998;45:273–7.
50. Kallen K. The impact of maternal smoking during pregnancy on delivery
outcome. Eur J Public Health. 2001;11:329–33.
51. Verkerk PH, Buitendijk SE, Verloove-Vanhorick SP. Differential misclassification
of alcohol and cigarette consumption by pregnancy outcome. Int J
Epidemiol. 1994;23:1218–25.
52. Maleckiene L, Nadisauskiene R, Bergstrom S. Scio-economic demographic
and obstetric risk factors for late death of unknown etiology in Luthuania: a
case—referent study. Acta Obstet Gynecol Scand. 2001;80:321–5.
53. Beyerleinl A, Von Kriesl R, Hummel M, Lack N, Schiessl B, Giani G.
Improvement in pregnancy-related outcomes in the offspring of
diabetic mothers in Bavaria, Germany, during 1987–2007. Diabet Med.
2010;27:1379–84.
54. Froen JF, Arnestad M, Vege A, Irgens, Rognum T, Saugstad O. Comparative
epidemiology of sudden infant death syndrome and sudden intrauterine
unexplained death. Arch Dis Child. 2002;87:118–21.
55. Little RE, Weinberg CR. Risk-factors for antepartum and intrapartum still-birth.
Am J Epidemiol. 1993;137:1177–89.
56. McCowan LM, George-Haddad M, Stacey T, Thompson JM. Fetal growth
restriction and other risk factors for stillbirth in a New Zealand setting. Aust
N Z J Obstet Gynaecol. 2007;47:450–6.
57. Aliyu MH, Salihu HM, Alio AP, Wilson RE, Charkrabarty S, Clayton HB.
Prenatal smoking among adolescents and risk of fetal demise before and
during labor. J Pediatr Adolesc Gynecol. 2010;23:129–35.
58. Bai J, Wong FW, Gyneshwar R, Stewart HC. Profile of maternal smokers and
their pregnancy outcomes in south western Sydney. J Obstet Gynaecol Res.
2000;26:127–32.
59. Flenady V. Causes and risk factors of stillbirth in Australia. Perinatal Society
of Austarlia and New Zealand Congress 2008. Gold Coast. Paediatr Child
Health. 2008:2-10.
60. Marrow RJ, Ritchie JW, Bull SB. Maternal cigarette smoking: the effects on
umbilical and uterine blood flow velocity. Am J Obstet Gynecol.
1988;159:1069–71.
61. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine.
Semin Perinatol. 1996;20:115–26.
62. Ylikorkala O, Viinikka L, Lehtovirta P. Effect of nicotine on fetal prostacyclin
and thromboxane in humans. Obstet Gynecol. 1985;66:102–5.
63. Bruner JP, Forouzan I. Smoking and Bucally administered nicotine. Acute
effect on uterine and umbilical artery Doppler flow velocity wave forms. J
Reprod Med. 1991;36:435–40.
64. Salihu HM, Aliyu HM, Kirby RS. In utero nicotine exposure and fetal growth
inhibition among twins. Am J Perinatol. 2005;22:421–7.
65. Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking
in pregnancy revisited: findings from a large population-based study. Am J
Obstet Gynecol. 2005;192:1856–63.66. Hajek P, Stead LF, West R, Jarvis M, Hartmann-Boyce J, Lancaster T. Relapse
prevention interventions for smoking cessation. Cochrane Database Syst
Rev 2013, Issue 8. Art. No.: CD003999. doi:10.1002/14651858.CD003999.pub4.
67. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J.
Pharmacological interventions for promoting smoking cessation during
pregnancy. Cochrane Database Syst Rev 2012, Issue 9. Art.
No.: CD010078. doi:10.1002/14651858.CD010078Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
